We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+14.61%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$51.6B
AUM Growth
+$5.68B
(+12%)
Cap. Flow
-$429M
Cap. Flow
% of AUM
-0.83%
Top 10 Holdings %
Top 10 Hldgs %
17.19%
Holding
3,020
New
40
Increased
1,306
Reduced
1,586
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$73.8M |
| 2 |
Amazon
AMZN
|
+$68.6M |
| 3 |
Apple
AAPL
|
+$64.9M |
| 4 |
Microsoft
MSFT
|
+$61.4M |
| 5 |
Meta Platforms (Facebook)
META
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$89.7M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$38.2M |
| 3 |
Wells Fargo
WFC
|
+$16.4M |
| 4 |
Walmart Inc
WMT
|
+$15.7M |
| 5 |
DNB
Dun & Bradstreet
DNB
|
+$15.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.09% |
| 2 | Financials | 15.13% |
| 3 | Healthcare | 13.65% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Industrials | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
2301
Crescent Biopharma
CBIO
$589M
| $540K | ﹤0.01% |
433
-13
| -3% | -$14.9K |
|
2302
Equity Bancshares
EQBK
$1.06B
| $539K | ﹤0.01% |
18,708
-371
| -2% | -$12.1K |
|
2303
Standard BioTools
LAB
$304M
| $539K | ﹤0.01% |
40,583
+6,094
| +18% | +$64.2K |
|
2304
Rocket Pharmaceuticals
RCKT
$388M
| $538K | ﹤0.01% |
30,695
+2,573
| +9% | +$40.6K |
|
|
DX
2305
Dynex Capital
DX
$3.18B
| $537K | ﹤0.01% |
29,418
+3,252
| +12% | +$59.4K |
|
2306
Rhythm Pharmaceuticals
RYTM
$7.52B
| $537K | ﹤0.01% |
19,603
+50
| +0.3% | +$1.44K |
|
2307
NRC Health Common Stock
NRC
$428M
| $535K | ﹤0.01% |
13,854
-464
| -3% | -$18.2K |
|
|
BLCM
2308
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $535K | ﹤0.01% |
15,863
-543
| -3% | -$18.1K |
|
|
OLBK
2309
DELISTED
Old Line Bancshares, Inc.
OLBK
| $534K | ﹤0.01% |
21,420
+238
| +1% | +$6.53K |
|
|
FBMS
2310
DELISTED
The First Bancshares, Inc.
FBMS
| $532K | ﹤0.01% |
17,201
-70
| -0.4% | -$2.21K |
|
2311
Accuray
ARAY
$33.5M
| $531K | ﹤0.01% |
111,392
+299
| +0.3% | +$1.36K |
|
2312
International Seaways
INSW
$4.64B
| $531K | ﹤0.01% |
30,969
-510
| -2% | -$9.01K |
|
2313
Voyager Therapeutics
VYGR
$188M
| $528K | ﹤0.01% |
27,594
-395
| -1% | -$5.14K |
|
|
MEET
2314
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $528K | ﹤0.01% |
104,966
+6,800
| +7% | +$37.9K |
|
|
ALTA
2315
DELISTED
Altabancorp
ALTA
| $527K | ﹤0.01% |
19,986
+212
| +1% | +$6.15K |
|
|
BVH
2316
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $525K | ﹤0.01% |
17,750
-261
| -1% | -$7.99K |
|
2317
Mitek Systems
MITK
$766M
| $522K | ﹤0.01% |
42,649
+230
| +0.5% | +$2.58K |
|
|
MOBL
2318
DELISTED
MobileIron, Inc.
MOBL
| $520K | ﹤0.01% |
95,100
+759
| +0.8% | +$3.74K |
|
2319
Intrepid Potash
IPI
$461M
| $516K | ﹤0.01% |
13,611
-77
| -0.6% | -$2.68K |
|
|
AD
2320
Array Digital Infrastructure
AD
$3.1B
| $513K | ﹤0.01% |
11,170
-7,197
| -39% | -$376K |
|
2321
CNB Financial Corp
CCNE
$1.04B
| $512K | ﹤0.01% |
20,250
-120
| -0.6% | -$3.12K |
|
2322
Old Second Bancorp
OSBC
$1.31B
| $510K | ﹤0.01% |
40,545
-567
| -1% | -$7.85K |
|
2323
Live Oak Bancshares
LOB
$1.98B
| $508K | ﹤0.01% |
34,741
-550
| -2% | -$8.45K |
|
|
ASXC
2324
DELISTED
Asensus Surgical, Inc.
ASXC
| $507K | ﹤0.01% |
16,386
+163
| +1% | +$5.46K |
|
2325
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11B
| $504K | ﹤0.01% |
+9,204
| New | +$486K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2019 Portfolio in Review
As of Q1 2019, RhumbLine Advisers held 3,020 positions worth $51.6B, up 12% from $46B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Trading was light in Q1 2019: portfolio turnover was 3.7%. RhumbLine Advisers opened 40 new positions and exited 73, leaving the 3,020-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2019 buy was Fox Class A: 602,636 shares worth $22.1M.
- RhumbLine Advisers added most to Walt Disney in Q1 2019, an estimated $73.8M increase.
- RhumbLine Advisers's biggest Q1 2019 reduction was Wells Fargo, cutting an estimated $16.4M.
- RhumbLine Advisers fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $89.7M.
- RhumbLine Advisers's ten largest holdings make up 17% of its $51.6B portfolio in Q1 2019.
- RhumbLine Advisers opened 40 new positions and closed 73 in Q1 2019.
- RhumbLine Advisers's portfolio value rose 12% quarter-over-quarter to $51.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2019, filed 1 May 2019.